Additional information
| Trade Name | Meqsel |
|---|---|
| Generic Name | Trametinib -Dimethylsulfoxide |
| Manufacturer | Novartis India Ltd |
| Drug Type | Oncology |
| Indication | Lung Cancer |
| Doasage Form | Tablet |
| Packaging | 30 tablets |
MEQSEL (Trametinib Dimethylsulfoxide)-0.5mg
Meqsel (Trametinib) is indicated for the treatment of patients with a type of skin cancer. It works by slowing the growth of cancer cells.
Meqsel in combination with dabrafenib is indicated for the treatment of patients with:
- unresectable or metastatic melanoma with a BRAF V600 mutation. As a monotherapy, it is indicated for the treatment of patients with unresectable or metastatic melanoma
- advanced non-small cell lung cancer (NSCLC)
- thyroid cancer
